Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

This study has been terminated.
(Despite extended efforts, unexpected difficulties prevented identifying proper candidates for the study.)
Sponsor:
Collaborator:
Forest Laboratories
Information provided by (Responsible Party):
Marek Belohlavek, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01605370
First received: May 22, 2012
Last updated: March 27, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)